日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Lipoic Acid for Treatment of Progressive Multiple Sclerosis: A Phase 2 Randomized Clinical Trial

硫辛酸治疗进行性多发性硬化症:一项 II 期随机临床试验

Spain, Rebecca I; Paz Soldán, M Mateo; Freedman, Mark S; Repovic, Pavle; Solomon, Andrew J; Rinker, John Robert; Wallin, Mitchell T; Haselkorn, Jodie K; Stuve, Olaf; Gross, Robert H; Waslo, Carin Stewart; Hildebrand, Andrea; Morris, Cynthia D; Mitchell, Julie; Turner, Aaron P; Schwartz, Daniel L; Metz, Jill; Rooney, William

Dynamics of Spinal Fluid Immune Cell Alterations Following Cladribine Tablet Treatment in Multiple Sclerosis

多发性硬化症患者服用克拉屈滨片剂后脊髓液免疫细胞变化的动态变化

Smirnov, Roman A; Cantoni, Claudia; Lee, Kenneth; Agnihotri, Rea A; Axtell, Robert C; Salter, Amber; Lancia, Samantha; Paley, Michael A; Hayward, Brooke; Korich, Julie; Evans, Emily; Pardo, Gabriel; Obeidat, Ahmed Z; Stuve, Olaf; Bar-Or, Amit; Artyomov, Maxim N; Cross, Anne H; Edelson, Brian T; Wu, Gregory F

Remyelination therapies are achievable in clinical practice-No

临床实践中能否实现髓鞘再生疗法?——否

Shirani, Afsaneh; Stuve, Olaf

Vedolizumab and the gut-CNS axis in multiple sclerosis: considering T cell licensing pathways

维多珠单抗与多发性硬化症中的肠-中枢神经系统轴:考虑T细胞激活途径

Shirani, Afsaneh; Stuve, Olaf

Informing Public Health Vaccination Policies Through Immune Surveillance and Serological Studies

通过免疫监测和血清学研究为公共卫生疫苗接种政策提供信息

Reder, Anthony T; Stuve, Olaf; Tankou, Stephanie K; Leist, Thomas P; Melin, M; Ekström, N; Solastie, A; Haveri, A; Liedes, O; Vara, S; Virta, C; Syrjänen, R; Palmu, A A; Nohymel, H

Leptin as a Potential Modifier of Neuroinflammation: Contrasting Roles in Alzheimer's Disease and Multiple Sclerosis

瘦素作为神经炎症的潜在调节因子:在阿尔茨海默病和多发性硬化症中发挥截然不同的作用

Abbasi Kasbi, Naghmeh; Stopschinski, Barbara Elena; Polyak, Alanna Gabrielle; Malladi, Agastya Reddy; Manouchehri, Navid; Scherer, Philipp E; Stuve, Olaf

Reporting patterns of multiple sclerosis with immune checkpoint inhibitors: analysis of the FDA Adverse Event Reporting System

免疫检查点抑制剂治疗多发性硬化症的报告模式:FDA不良事件报告系统分析

Shirani, Afsaneh; Goldlust, Samuel A; Stuve, Olaf

A review of Bruton's tyrosine kinase inhibitors in multiple sclerosis

对布鲁顿酪氨酸激酶抑制剂在多发性硬化症中的应用进行综述

Airas, Laura; Bermel, Robert A; Chitnis, Tanuja; Hartung, Hans-Peter; Nakahara, Jin; Stuve, Olaf; Williams, Mitzi J; Kieseier, Bernd C; Wiendl, Heinz

Cladribine tablets after treatment with natalizumab (CLADRINA) - rationale and design

克拉屈滨片在接受那他珠单抗治疗后(CLADRINA)——原理和设计

Sguigna, Peter V; Hussain, Rehana Z; Okai, Annette; Blackburn, Kyle M; Tardo, Lauren; Madinawala, Mariam; Korich, Julie; Lebson, Lori A; Kaplan, Jeffrey; Salter, Amber; Manouchehri, Navid; Stuve, Olaf

Exploring the association between weight loss-inducing medications and multiple sclerosis: insights from the FDA adverse event reporting system database

探索减肥药物与多发性硬化症之间的关联:来自FDA不良事件报告系统数据库的启示

Shirani, Afsaneh; Cross, Anne H; Stuve, Olaf